| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $475.2M | +17.2% |
| Cost of Revenue | $172.3M | +1.4% |
| Gross Profit | $302.9M | +28.6% |
| R&D Expense | $77.2M | +21.0% |
| SG&A Expense | $60.4M | +10.1% |
| Operating Income | -$16.5M | +64.9% |
| Interest Expense | $24.6M | -51.2% |
| Pre-tax Income | -$42.4M | +65.4% |
| Income Tax | -$8.1M | +75.9% |
| Net Income | -$34.2M | +61.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.0M | +12.7% |
| Accounts Receivable | $71.4M | +38.4% |
| Current Assets | $285.0M | +15.5% |
| Total Assets | $2.15B | +0.9% |
| Current Liabilities | $334.1M | +12.4% |
| Long-term Debt | $496.3M | -0.8% |
| Total Liabilities | $877.4M | +2.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $140.3M | +33.4% |
| Capital Expenditures | $6.3M | +48.4% |
| Investing Cash Flow | -$115.3M | -857.1% |
| Financing Cash Flow | -$1.7M | +98.3% |
| Free Cash Flow | $133.9M | +32.8% |
| Stockholders' Equity |
| $1.28B |
| +0.1% |